Enveric Intangible Assets from 2010 to 2026
| ENVB Stock | USD 2.91 0.16 5.21% |
Intangible Assets | First Reported 1995-12-31 | Previous Quarter 84.4 K | Current Value 42.2 K | Quarterly Volatility 5.2 M |
Check Enveric Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enveric Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 572.8 K, Interest Expense of 3.2 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 4.91, Dividend Yield of 31.8 K or PTB Ratio of 1.86. Enveric financial statements analysis is a perfect complement when working with Enveric Biosciences Valuation or Volatility modules.
Enveric | Intangible Assets | Build AI portfolio with Enveric Stock |
Analyzing Enveric Biosciences's Intangible Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Intangible Assets has evolved provides context for assessing Enveric Biosciences's current valuation and future prospects.
Latest Enveric Biosciences' Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of Enveric Biosciences over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Enveric Biosciences' Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enveric Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
Enveric Intangible Assets Regression Statistics
| Arithmetic Mean | 3,108,134 | |
| Geometric Mean | 1,142,132 | |
| Coefficient Of Variation | 98.01 | |
| Mean Deviation | 2,236,685 | |
| Median | 3,114,513 | |
| Standard Deviation | 3,046,309 | |
| Sample Variance | 9.3T | |
| Range | 9.4M | |
| R-Value | (0.30) | |
| Mean Square Error | 9T | |
| R-Squared | 0.09 | |
| Significance | 0.23 | |
| Slope | (183,666) | |
| Total Sum of Squares | 148.5T |
Enveric Intangible Assets History
About Enveric Biosciences Financial Statements
Enveric Biosciences stakeholders use historical fundamental indicators, such as Enveric Biosciences' Intangible Assets, to determine how well the company is positioned to perform in the future. Although Enveric Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Enveric Biosciences' assets and liabilities are reflected in the revenues and expenses on Enveric Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Enveric Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 48.5 K | 46.1 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Enveric Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enveric Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enveric Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enveric Biosciences Stock:Check out the analysis of Enveric Biosciences Correlation against competitors. For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. Projected growth potential of Enveric fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Enveric Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (119.64) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
Understanding Enveric Biosciences requires distinguishing between market price and book value, where the latter reflects Enveric's accounting equity. The concept of intrinsic value—what Enveric Biosciences' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Enveric Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Enveric Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Enveric Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Enveric Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.